围产期心肌病诊治

刘燕燕,冯玲

中国实用妇科与产科杂志 ›› 2019, Vol. 35 ›› Issue (11) : 1224-1228.

中国实用妇科与产科杂志 ›› 2019, Vol. 35 ›› Issue (11) : 1224-1228. DOI: 10.19538/j.fk2019110111
专题笔谈

围产期心肌病诊治

作者信息 +

Diagnosis and treatment of peripartum cardiomyopathy.

Author information +
文章历史 +

摘要

围产期心肌病(PPCM)典型症状以心力衰竭、呼吸困难为主要表现,超声心动图是首选检查。溴隐亭及口服抗心力衰竭药物是治疗主要手段,对于血流动力学不稳定的心力衰竭孕妇,无论孕周大小均应终止妊娠。孕产妇病死率的预测指标为纽约心脏病协会(NYHA)Ⅲ/Ⅳ分级和左心室射血分数(LVEF)<40%。

Abstract

Typical symptoms of peripartum cardiomyopathy(PPCM)are heart failure and dyspnea.Echocardiography is the first choice.Bromocriptine and oral drugs for heart failure are the main treatments.For pregnant women with heart failure with hemodynamic instability,pregnancy should be terminated regardless of the size of the gestational age.The predictors of maternal mortality are NYHA class Ⅲ/Ⅳ and left ventricular ejection fraction(LVEF)<40%.

关键词

围产期心肌病 / 溴隐亭 / 心力衰竭 / 左心室射血分数 / 预测

Key words

peripartum cardiomyopathy / bromocriptine / heart failure / left ventricular ejection fraction / prediction

引用本文

导出引用
刘燕燕,冯玲. 围产期心肌病诊治[J]. 中国实用妇科与产科杂志. 2019, 35(11): 1224-1228 https://doi.org/10.19538/j.fk2019110111
LIU Yan-yan,FENG Ling. Diagnosis and treatment of peripartum cardiomyopathy.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2019, 35(11): 1224-1228 https://doi.org/10.19538/j.fk2019110111
中图分类号: R714.252   

基金

“生殖健康及重大出生缺陷防控研究”国家重点研发计划(2018YFC1002900)


Accesses

Citation

Detail

段落导航
相关文章

/